| Literature DB >> 30779911 |
Rong Zhang1, Weipin Zhou2, Zhijun Yu2, Ling Yang2, Guangqi Liu2, Haotian Yu2, Qianyi Zhou2, Zhenli Min2, Chunxiang Zhang3, Qingming Wu2, Xia-Min Hu4, Qiong Yuan5.
Abstract
Brain stroke is one of the leading causes of death worldwide. We explored a potential stroke-related role for a newly found microRNA, miR-1247-3p, and one of its target genes, caspase-2, predicted by TargetScanVert. In the present study, we found that miR-1247-3p was downregulated during ischemia/reperfusion (I/R) and that LV-miR-1247-3p overexpression attenuated brain impairment induced by I/R. Similar results were observed in neuro2a (N2a) cells treated with oxygen-glucose deprivation/reoxygenation (OGD/R). Caspase-2 was upregulated in the I/R and OGD/R model, while Z-VDVAD-FMK - the inhibitor of caspase-2-inhibited apoptosis of N2a cells induced by OGD/R. An miR-1247-3p mimic inhibited caspase-2 expression and attenuated apoptosis of N2a cells induced by OGD/R. Myocardin-related transcription factor-A (MRTF-A) overexpression upregulated miR-1247 and mature miR-1247-3p levels and attenuated apoptosis induced by OGD/R, whereas its anti-apoptotic function could be blocked by a miR-1247-3p inhibitor. Hence, we conclude that miR-1247-3p may protect cells during brain stroke. This study offers insights for the development of effective therapeutics for promoting the survival of cerebral neurons during brain I/R injury.Entities:
Keywords: Apoptosis; Caspase-2; Ischemia/reperfusion; Myocardin-related transcription factor-A; Stroke; miR-1247-3p
Year: 2019 PMID: 30779911 DOI: 10.1016/j.brainres.2019.02.020
Source DB: PubMed Journal: Brain Res ISSN: 0006-8993 Impact factor: 3.252